APR 08, 2020 12:53 PM PDT

How the Skin Shields Against Zika Infection

WRITTEN BY: Tara Fernandez

Aedes mosquitoes are native of Africa but are commonly found in regions of the Americas, Asia, and the Pacific. These daytime-active bloodsuckers are notorious for being a vector responsible for transmitting a number of diseases: dengue fever, Chikungunya, and Zika fever, to name a few.

To fully understand the molecular dynamics of Zika virus infection, scientists are starting from the beginning — the site of the mosquito bite. A team led by a professor of dermatology at Duke, Amanda MacLeod, used mouse models to map how the skin acts as an antiviral shield during Zika virus transmission in an effort to resist infection. The study was published recently in Science Advances.

The researchers identified that an immune cytokine, interleukin 27 (IL-27), plays an important role in “calling” for backup from other immune cells when the Zika virus penetrates the skin. This innate immune response also stimulates the production of antiviral proteins to neutralize the virus. Fascinatingly, when the virus is introduced into the body through a different point of entry, IL-27 responses are not activated, thereby exacerbating the neurological symptoms of Zika disease.

"What's particularly interesting is that, especially in the absence of acquired immunity and memory responses, our natural innate immune system is highly relevant as it acts much faster—anywhere from hours to a day—than acquired immunity. Most vaccines require boosters over months or years to attain host immunity," says MacLeod.

When the virus evades the immune system, the resulting infection causes a range of symptoms that mostly feature a mild rash, fever, and headache. The consequences of Zika disease are far more devastating when a pregnant woman is bitten by a virus-transmitting mosquito. In these cases, brain deformation and microcephaly (a condition where the infant’s head circumference is much smaller than average) can result.

 

 

The World Health Organization has been calling for a vaccine to be developed quickly to prevent Zika outbreaks, particularly in rural communities. As of 2016, 18 companies were actively chasing the development of a potential vaccine, though experts predict these will take at least a decade to hit the market.

Research findings on the natural protective antiviral pathways, such as those from MacLeod and colleagues, will greatly impact the development of novel preventative and therapeutic strategies against Zika disease.

Speaking on the potential to leverage this data towards thwarting other viral infections, MacLeod commented, "Whether our results could also potentially be applied to other viral pathogens such as SARS Cov-2, the pathogen that causes COVID-19, remains to be tested in future studies.”

 

 

Sources: Medical XPress, Science Advances

 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
OCT 14, 2020
Immunology
Self-Healing Microcapsules Make Promising Leukemia Vaccines
OCT 14, 2020
Self-Healing Microcapsules Make Promising Leukemia Vaccines
Leukemia is a cancer affecting tissues in the body that produce blood cells, including the bone marrow and the lymphatic ...
OCT 21, 2020
Immunology
CNS's immune cells - Microglia are involved in the exacerbation of MS
OCT 21, 2020
CNS's immune cells - Microglia are involved in the exacerbation of MS
Multiple sclerosis (MS) is one of the most progressive autoimmune diseases that affect the central nervous system where ...
OCT 29, 2020
Cell & Molecular Biology
How Does the Immune System Handle the Microbiome?
OCT 29, 2020
How Does the Immune System Handle the Microbiome?
The human body plays host to trillions of microbes, and many of them live in our gastrointestinal tract; these microorga ...
NOV 09, 2020
Drug Discovery & Development
COVID-19 Vaccine by Pfizer More than 90% Effective
NOV 09, 2020
COVID-19 Vaccine by Pfizer More than 90% Effective
A preliminary analysis of Pfizer and BioNTech's COVID-19 vaccine shows that it can prevent over 90% of people from c ...
NOV 16, 2020
Immunology
Australian COVID-19 vaccine is promising and could be released next year
NOV 16, 2020
Australian COVID-19 vaccine is promising and could be released next year
Pharmaceutical companies worldwide are racing to develop a COVID-19 vaccine that will hopefully end this pandemic and he ...
NOV 17, 2020
Drug Discovery & Development
Antibiotics Before Age 2 Linked to Childhood Health Conditions
NOV 17, 2020
Antibiotics Before Age 2 Linked to Childhood Health Conditions
Researchers from Mayo Clinic have found a link between children aged two and under taking antibiotics and an increased r ...
Loading Comments...